Has Jun Kim received payments from drug or device companies?

Yes. Drug and device makers reported $1,664 in general payments to Jun Kim across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jun Kim did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jun Kim come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jun Kim

Obstetrics & Gynecology · East Chicago, INNPI 1336411610

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $642 and has fallen 87.6% since, to $79 in 2025.

$1,664in general payments, 2019–2025

Across 86 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vanda Pharmaceuticals Inc.$375
AbbVie$362
Amgen$89
Lundbeck LLC$81
Amarin Pharma, Inc.$71
Biohaven Pharmaceuticals, Inc.$56
plus $630 from 25 others

What the payments were for

Food & beverage$1,664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vanda Pharmaceuticals Inc.	13	$375
AbbVie	19	$362
Amgen	5	$89
Lundbeck LLC	5	$81
Amarin Pharma, Inc.	5	$71
Biohaven Pharmaceuticals, Inc.	4	$56
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$49
Organon	2	$47
Sunovion Pharmaceuticals Inc.	3	$47
Otsuka America Pharmaceutical, Inc.	2	$46
Indivior Inc.	2	$36
Teva Pharmaceuticals USA, Inc.	2	$34
Exeltis, USA Inc.	2	$31
Axsome Therapeutics, Inc.	1	$31
Corium, LLC	1	$26
Coopersurgical, Inc.	1	$25
Duchesnay USA Incorporated	2	$24
Johnson & Johnson	1	$24
Sumitomo Pharma America, Inc.	1	$22
Biohaven Pharmaceutical Holding Company Ltd.	1	$20
Alvogen Inc	1	$20
Alkermes, Inc.	1	$18
Cequr Corporation	1	$17
Bayer	1	$17
Convatec Inc.	1	$16
Merck	1	$15
Novo Nordisk	1	$14
Eisai Inc.	1	$14
Astellas Pharma US Inc	1	$13
Roche Diagnostics Corporation	1	$12
AstraZeneca	1	$12

How this compares

$1,664 in reported general payments places this provider in the 70th percentile of 743 obstetrics & gynecology providers in Indiana.

See all obstetrics & gynecology providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Norethindrone	19	$403
Metronidazole	16	$52
Fluconazole	11	$31

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in East Chicago

Ashley ScottFort Wayne$124K
Candace WestgateIndianapolis$123K
Keith RamseyLake Station$116K
Stefanie FloraCarmel$106K
Lori DavidsonGreenwood$54K
Julius Ellisla Porte$53K
Emmary ButlerWinchester$45K
Enrique InfanteElkhart$41K
Paul MorrisonNewburgh$38K
Joseph ShinnLafayette$34K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →